New York State Common Retirement Fund
VYGR icon

New York State Common Retirement Fund’s Voyager Therapeutics VYGR Stock Holding History

New York State Common Retirement Fund’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.6K Hold
12,732
– – ﹤0.01% 3031
2026
Q1 		$49.1K Hold
12,732
– – ﹤0.01% 2822
2025
Q4 		$50K Hold
12,732
– – ﹤0.01% 2907
2025
Q3 		$59.5K Hold
12,732
– – ﹤0.01% 2890
2025
Q2 		$39.6K Hold
12,732
– – ﹤0.01% 3003
2025
Q1 		$43K Hold
12,732
– – ﹤0.01% 2828
2024
Q4 		$72.2K Hold
12,732
– – ﹤0.01% 2729
2024
Q3 		$74.5K Hold
12,732
– – ﹤0.01% 2731
2024
Q2 		$101K Buy
12,732
+97
+0.8% +$813 ﹤0.01% 2829
2024
Q1 		$118K Sell
12,635
-28
-0.2% -$236 ﹤0.01% 2672
2023
Q4 		$107K Sell
12,663
-63
-0.5% -$457 ﹤0.01% 2726
2023
Q3 		$98.6K Buy
12,726
+326
+3% +$2.98K ﹤0.01% 2731
2023
Q2 		$142K Buy
+12,400
New +$128K ﹤0.01% 2645
2021
Q3 		– Sell
-229
Closed -$1K – 3531
2021
Q2 		$1K Sell
229
-12,671
-98% -$57.4K ﹤0.01% 3479
2021
Q1 		$61K Hold
12,900
– – ﹤0.01% 3177
2020
Q4 		$92K Sell
12,900
-11,400
-47% -$110K ﹤0.01% 3054
2020
Q3 		$259K Hold
24,300
– – ﹤0.01% 2537
2020
Q2 		$307K Buy
24,300
+8,600
+55% +$100K ﹤0.01% 2458
2020
Q1 		$144K Sell
15,700
-9,100
-37% -$104K ﹤0.01% 2619
2019
Q4 		$346K Sell
24,800
-700
-3% -$10.2K ﹤0.01% 2467
2019
Q3 		$439K Hold
25,500
– – ﹤0.01% 2390
2019
Q2 		$694K Buy
25,500
+11,100
+77% +$254K ﹤0.01% 2207
2019
Q1 		$276K Sell
14,400
-9,400
-39% -$122K ﹤0.01% 2573
2018
Q4 		$224K Hold
23,800
– – ﹤0.01% 2664
2018
Q3 		$450K Hold
23,800
– – ﹤0.01% 2463
2018
Q2 		$465K Buy
23,800
+6,000
+34% +$119K ﹤0.01% 2480
2018
Q1 		$334K Buy
17,800
+2,100
+13% +$45.4K ﹤0.01% 2524
2017
Q4 		$261K Buy
15,700
+2,000
+15% +$34.3K ﹤0.01% 2637
2017
Q3 		$282K Buy
13,700
+1,600
+13% +$18.1K ﹤0.01% 2620
2017
Q2 		$108K Sell
12,100
-1
-0% -$10 ﹤0.01% 3077
2017
Q1 		$160K Buy
12,101
+1
+0% +$12 ﹤0.01% 2845
2016
Q4 		$154K Hold
12,100
– – ﹤0.01% 2858
2016
Q3 		$145K Buy
12,100
+9,200
+317% +$125K ﹤0.01% 2880
2016
Q2 		$32K Hold
2,900
– – ﹤0.01% 3110
2016
Q1 		$25K Buy
+2,900
New +$32.9K ﹤0.01% 3108

Other funds holding VYGR

EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
PFGIA
Patriot Financial Group Insurance Agency Westborough, Massachusetts $974M AUM 29.77% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
HPCM
Hunter Perkins Capital Management Lombard, Illinois $446M AUM 25.88% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AIP
Almanack Investment Partners Wayne, Pennsylvania $785M AUM 34.37% 1-Year Est. Return

New York State Common Retirement Fund's VYGR Position: Q2 2026 in Review

New York State Common Retirement Fund held its Voyager Therapeutics (VYGR) position steady in Q2 2026 at 12,732 shares worth $44.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3031.

New York State Common Retirement Fund first reported a position in VYGR in Q1 2016 and has held it in 35 quarters since. The position peaked at $694K in Q2 2019. 28 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • New York State Common Retirement Fund held 12,732 shares of Voyager Therapeutics worth $44.6K as of Q2 2026.
  • New York State Common Retirement Fund left its Voyager Therapeutics share count unchanged in Q2 2026.
  • Voyager Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #3031 holding.
  • New York State Common Retirement Fund first reported a position in Voyager Therapeutics in Q1 2016 and has held it in 35 quarters since.
  • New York State Common Retirement Fund's Voyager Therapeutics position peaked at $694K in Q2 2019.
  • 28 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.